Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients

Bone Marrow Transplantation

Volumn 35, Issue 12, 2005, Pages 1171-1177

  Kyle, U G ^a   Chalandon, Y ^a   Miralbell, R ^a   Karsegard, V L ^a   Hans, D ^a   Trombetti, A ^a   Rizzoli, R ^a   Helg, C ^a   Pichard, Claude ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Body composition; Fat mass; Fat free mass; Longitudinal follow up

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; AMPHOTERICIN B LIPID COMPLEX; BUSULFAN; CLONAZEPAM; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; FLUCONAZOLE; FLUDARABINE; FOSCARNET; GANCICLOVIR; HEPARIN; MESNA; METHOTREXATE; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ARTICLE; BODY COMPOSITION; CHRONIC GRAFT VERSUS HOST DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; INFECTION; KIDNEY DISEASE; LEAN BODY WEIGHT; LIVER VENOOCCLUSIVE DISEASE; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; STEROID THERAPY; VOLUNTEER;

BODY COMPOSITION; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KARNOFSKY PERFORMANCE STATUS; LONGITUDINAL STUDIES; ODDS RATIO; RETROSPECTIVE STUDIES; STEROIDS; TRANSPLANTATION, HOMOLOGOUS;

EID: 21244443428     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704996     Document Type: Article

References (34)

1. Iestra JA, Fibbe WE, Zwinderman AH et al. Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies. Bone Marrow Transplant 1999; 23: 933-939.
2. Laviano A, Meguid MM. Nutritional issues in cancer management. Nutrition 1996; 12: 358-371.
3. Dickson TM, Kusnierz-Glaz CR, Blume KG et al. Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. Biol Blood Marrow Transplant 1999; 5: 299-305.
4. Deeg HJ, Seidel K, Bruemmer B et al. Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant 1995; 15: 461-468.
5. Meloni G, Proia A, Capria S et al. Obesity and autologous stem cell transplantation in acute myeloid leukemia. Bone Marrow Transplant 2001; 28: 365-367.
6. Pichard C, Kyle UG, Morabia A et al. Nutritional assessment: lean body mass depletion at hospital admission is associated with increased length of stay. Am J Clin Nutr 2004; 79: 613-618.
7. Kinney T. Glucocorticoid-induced muscle atrophy. J Cardiopulm Rehab 1997; 17: 76-84.
8. Hickson RC, Marone JR. Exercise and inhibition of glucocorticoid-induced muscle atrophy. Exerc Sport Sci Rev 1993; 21: 135-167.
9. Kyle UG, Piccoli A, Pichard C. Body composition measurements: interpretation finally made easy for clinical use. Curr Opin Clin Nutr Metab Care 2003; 6: 387-393.
10. Baumgartner RN, Koehler KM, Gallagher D et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-763.
11. Genton L, Hans D, Kyle UG, Pichard C. Dual-energy X-ray absorptiometry and body composition: differences between devices and comparison with reference methods. Nutrition 2002; 18: 66-70.
12. Buchs N, Helg C, Collao C et al. Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss. Osteoporosis Int 1998; 12: 880-886.
13. Bieri S, Helg C, Chapuis B, Miralbell R. Total body irradiation before allogeneic bone marrow transplantation: is more dose better? Int J Radiat Oncol Biol Phys 2001; 49: 1071-1077.
14. Storb R, Pepe M, Anasetti C et al. What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants? Blood 1990; 76: 1037-1045.
15. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729-735.
16. Kottaridis PD, Milligan DW, Chopra R et al. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood 2000; 96: 2419-2425.
17. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
18. Einsele H, Elminger G, Hebart H et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995; 86: 2815-2820.
19. Attal M, Huguet F, Rubie H et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial. Blood 1992; 79: 2834-2840.
20. Chalandon Y, Roosnek E, Mermillod B et al. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 347-354.
21. Kyle UG, Genton L, Karsegard L et al. Single prediction equation for bioelectrical impedance analysis in adults aged 20-94 years. Nutrition 2001; 17: 248-253.
22. Mazess RB, Peppler WW, Gibbons M. Total body composition by dual-photon (153 Gd) absorptiometry. Am J Clin Nutr 1990; 40: 834-839.
23. Slosman DO, Casez JP, Pichard C et al. Assessment of wholebody composition using dual X-ray absorptiometry. Radiology 1992; 185: 593-598.
24. Blake GM, Patel R, Lewis MK. New generation dual X-ray absorptiometry scanners increase dose to patients and staff. J Bone Miner Res 1996; 11: S157.
25. Lewis MK, Blake GM, Fogelman I. Patient dose in dual X-ray absorptiometry. Osteoporosis Int 1994; 4: 11-15.
26. Kyle UG, Schutz Y, Dupertuis YM, Pichard C. Body composition interpretation: contribution of fat-free mass index and body fat mass index. Nutrition 2003; 19: 597-604.
27. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 1984; 53: 2002-2007.
28. Kauppila M, Koskinen P, Irjala K et al. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults. Bone Marrow Transplant 1998; 22: 331-337.
29. Weisdorf SA, Salati LM, Longsdorf JA et al. Graft-versus-host disease of the intestine: a protein losing enteropathy characterized by fecal alpha 1-antitrypsin. Gastroenterology 1983; 85: 1076-1081.
30. Guiot HF, Biemond J, Klasen E et al. Protein loss during acute graft-versus-host disease: diagnostic and clinical significance. Eur J Haematol 1987; 38: 187-196.
31. Herrmann VM, Petruska PJ. Nutrition support in bone marrow transplant recipients. Nutr Clin Pract 1993; 8: 19-27.
32. Nysom K, Holm K, Michaelsen KF et al. Degree of fatness after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant 2001; 27: 817-820.
33. Couto-Silva AC, Trivin C, Esperou H et al. Changes in height, weight and plasma leptin after bone marrow transplantation. Bone Marrow Transplant 2000; 26: 1205-1210.
34. Horber FF, Marsh HM, Haymond MW. Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes 1991; 40: 141-149.